PDS Biotechnology Corporation (PDSB) NASDAQ
1.17
+0.03(+2.63%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.17
+0.03(+2.63%)
Currency In USD
| Market Cap | 35.71M |
| Enterprise Value | 25.92M |
| P/E Ratio | -1.93 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 16.54 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.35 |
| Return On Equity | -3.46 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -30.3M |
| Net Income | -34.5M |
| Diluted EPS | -0.74 |
| Total Cash | 21.66M |
| Total Cash/Share | 0.39 |
| Total Debt | 15.86M |
| Total Debt/Equity | 4.07 |
| Current Ratio | 2.26 |
| Book Value Per Share | 0.07 |
| 52-Week Change | -17.02 |
| 52-Week High | 1.92 |
| 52-Week Low | 0.51 |
| Moving Average 50 Days | 1.01 |
| Moving Average 200 Days | 0.94 |
| Average Volume | 1.1M |
| Shares Outstanding | 55.82M |
| % Held by Institutions | 10.88 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 18, 2019 |